Usman, M.,
Beilerli, A.,
Sufianov, A.,
Kudryashov, V.,
Ilyasova, T.,
Balaev, P.,
Danilov, A.,
Lu, H.,
Gareev, I. (2023) (lncRNAs) and circular
RNAs (circRNAs) into clinical medicine as biomarkers and therapeutic
targets.
Guan, Xiaoxiang,
Zhang, Yiwei,
Gareev, Ilgiz,
Beylerli, Ozal,
Li, Xinyuan,
Lu, Guitian,
Lv, Lin,
Hai, Xin (2023) MiR-499a prevents astrocytes mediated inflammation in ischemic stroke by
targeting PTEN
Gareev, Ilgiz,
Beylerli, Ozal,
Ahmad, Aamir,
Ilyasova, Tatiana,
Shi, Huaizhang,
Chekhonin, Vladimir (2024) the sponging of microRNAs (miRNAs) and can also be used as therapeutic
targets and biomarkers. Increasing
conducted. MiRNA
targets sites are a promising new area of research. In this study, we analyzed
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Y.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) studies in clinical laboratories. In addition, the question of the
target orientation of exosomes
Beylerli, Ozal,
Gareev, Ilgiz,
Musaev, Elmar,
Roumiantsev, Sergey,
Chekhonin, Vladimir,
Ahmad, Aamir,
Chao, Yuan,
Yang, Guang (2025) and genomics have enabled the identification of specific molecular pathways and
targets, paving the way
Gareev, Ilgiz,
Encarnacion Ramirez, Manuel de Jesus,
Nurmukhametov, Renat,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Beilerli, Aferin,
Wang, Chunlei (2023) biomarkers and therapeutic
targets specifically tailored for glioma. In recent years, long non-coding RNAs
Urakov, Aleksandr L.,
Tyurin, Anton V.,
Shchekin, Vlas S.,
Siddikov, Olim A.,
Abdurakhmanov, Ilhomjon R.,
Gabdrakhimova, Renata A.,
Samorodov, Aleksandr V. (2024) , and inflammatory diseases makes ubiquitylation of the enzymes involved a promising
target to develop new therapy